Cost-utility analysis of long-acting cabotegravir plus rilpivirine for the treatment of HIV infection in the United Kingdom

被引：0
|
作者：
Parker, B. [1 ]
Chounta, V. [2 ]
Gait, C. [3 ]
Hayward, O. [4 ]
Hunjan, M. [3 ]
Schroeder, M. [2 ]
Jacob, I. [1 ]
Van de Velde, N. [2 ]
机构：
[1] Hlth Econ & Outcomes Res Ltd, Hlth Econ, Cardiff, Wales
[2] ViiV Healthcare, Global Hlth Outcomes, London, England
[3] GSK, Hlth Outcomes, London, England
[4] Hlth Econ & Outcomes Res Ltd, Med Writing, Cardiff, Wales
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P030
引用
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF LONG-ACTING CABOTEGRAVIR PLUS LONG-ACTING RILPIVIRINE FOR THE TREATMENT OF HIV-1 IN TAIWAN
    Wen, Y. C.
    Ou, H. T.
    Tien, K.
    Harrison, C.
    Omonmhenle, D.
    Turner, M.
    Anderson, S. J.
    Jacob, I
    VALUE IN HEALTH, 2023, 26 (06) : S145 - S145
  • [2] Long-acting cabotegravir plus rilpivirine for HIV treatment: FLAIR week 96 results
    Orkin, C.
    Oka, S.
    Philibert, P.
    Brinson, C.
    Bassa, A. C.
    Gusev, D.
    Degen, O.
    Gonzalez Garcia, J.
    D'Amico, R.
    Dorey, D.
    Griffith, S.
    Margolis, D. A.
    St Clair, M.
    Williams, P.
    Spreen, W. R.
    HIV MEDICINE, 2020, 21 : 14 - 14
  • [3] An evaluation of long-acting cabotegravir plus rilpivirine for the treatment of virologically suppressed adults living with HIV
    Qazzaz, Hamdi
    Parganas, Christopher
    Cory, Theodore James
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (13) : 1485 - 1495
  • [4] Acceptability of Long-Acting Cabotegravir plus Rilpivirine in a Large, Urban, Ambulatory HIV Clinic
    Luc, Casey Morgan
    Max, Blake
    Perez, Sarah
    Herrera, Kara
    Huhn, Gregory
    Dworkin, Mark S.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2024, 97 (04) : 409 - 415
  • [5] Long-Acting Injectable Cabotegravir and Rilpivirine in a Pregnant Woman With HIV
    van der Wekken-Pas, Lena
    Weiss, Fabian
    Simon-Zuber, Charlotte
    Sebisch, Rena
    Wiese, Carmen
    van Leeuwen, Elisabeth
    Burger, David
    Colbers, Angela
    CLINICAL INFECTIOUS DISEASES, 2024, 79 (06) : 1468 - 1471
  • [6] Rilpivirine long-acting for the prevention and treatment of HIV infection
    Ferretti, Francesca
    Boffito, Marta
    CURRENT OPINION IN HIV AND AIDS, 2018, 13 (04) : 300 - 307
  • [7] Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection
    Orkin, Chloe O. C.
    Arasteh, Keikawus A. K.
    Hernandez-Mora, M. Gorgolas M. G. H. M.
    Pokrovsky, Vadim P. V.
    Overton, Edgar T. O. E. T.
    Girard, Pierre-Marie G. P. M.
    Oka, Shinichi O. S.
    Walmsley, Sharon W. S.
    Bettacchi, Chris B. C.
    Brinson, Cynthia B. C.
    Philibert, Patrick P. P.
    Lombaard, Johan L. J.
    Clair, Marty C. M.
    Crauwels, Herta C. H.
    Ford, Susan L. F. S. L.
    Patel, Parul P. P.
    Chounta, Vasiliki C. V.
    D'Amico, Ronald D. R.
    Vanveggel, Simon V. S.
    Dorey, David D. D.
    Cutrell, Amy C. A.
    Griffith, Sandy G. S.
    Margolis, David A. M. D. A.
    Williams, Peter E. W. P. E.
    Parys, Wim P. W.
    Smith, Kimberly Y. S. K. Y.
    Spreen, William R. S. W. R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (12): : 1124 - 1135
  • [8] Evaluating cabotegravir/rilpivirine long-acting, injectable in the treatment of HIV infection: emerging data and therapeutic potential
    Fernandez, Cristina
    van Halsema, Clare L.
    HIV AIDS-RESEARCH AND PALLIATIVE CARE, 2019, 11 : 179 - 192
  • [9] The use and utility of toolkits in supporting cabotegravir plus rilpivirine long-acting implementation in the CARISEL (Cabotegravir And Rilpivirine Implementation Study in European Locations) study
    Trehan, Rekha
    Gutner, Cassidy
    Okoli, Chinyere
    Ghosn, Jade
    Vera, Francisco
    Florence, Eric
    Lutz, Thomas
    van der Valk, Marc
    Czarnogorski, Maggie
    HIV MEDICINE, 2023, 24 : 93 - 93
  • [10] The future of long-acting cabotegravir plus rilpivirine therapy: deeds and misconceptions
    Rusconi, Stefano
    Santoro, Maria M.
    Capetti, Amedeo F.
    Gianotti, Nicola
    Zazzi, Maurizio
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2022, 60 (03)
12345